HIF-1-dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistance

David L. Schwartz, James Bankson, Luc Bidaut, Yi He, Ryan Williams, Robert Lemos, Arun Kumar Thitai, Junghwan Oh, Andrei Volgin, Suren Soghomonyan, Hsin-Hsien Yeh, Ryuichi Nishii, Uday Mukhopadhay, Mian Alauddin, Ioseb Mushkudiani, Norihito Kuno, Sunil Krishnan, William Bornman, Stephen Y. Lai, Garth PowisJohn Hazle, Juri Gelovani

    Research output: Contribution to journalArticlepeer-review

    24 Citations (Scopus)


    Purpose: Hypoxia-inducible factor 1 (HIF-1) promotes cancer cell survival and tumor progression. The specific role played by HIF-1 and tumor-stromal interactions toward determining tumor resistance to radiation treatment remains undefined. We applied a multimodality preclinical imaging platform to mechanistically characterize tumor response to radiation, with a focus on HIF-1-dependent resistance pathways.

    Methods: C6 glioma and HN5 human squamous carcinoma cells were stably transfected with a dual HIF-1 signaling reporter construct (dxHRE-tk/eGFP-cmvRed2XPRT). Reporter cells were serially interrogated in vitro before and after irradiation as monolayer and multicellular spheroid cultures and as subcutaneous xenografts in nu/nu mice.

    Results: In vitro, single-dose irradiation of C6 and HN5 reporter cells modestly impacted HIF-1 signaling in normoxic monolayers and inhibited HIF-1 signaling in maturing spheroids. In contrast, irradiation of C6 or HN5 reporter xenografts with 8 Gy in vivo elicited marked upregulation of HIF-1 signaling and downstream proangiogenic signaling at 48 hours which preceded recovery of tumor growth. In situ ultrasound imaging and dynamic contrast-enhanced (DCE) MRI indicated that HIF-1 signaling followed acute disruption of stromal vascular function. High-resolution positron emission tomography and dual-contrast DCE-MRI of immobilized dorsal skin window tumors confirmed postradiotherapy HIF-1 signaling to spatiotemporally coincide with impaired stromal vascular function. Targeted disruption of HIF-1 signaling established this pathway to be a determinant of tumor radioresistance.

    Conclusions: Our results illustrate that tumor radioresistance is mediated by a capacity to compensate for stromal vascular disruption through HIF-1-dependent proangiogenic signaling and that clinically relevant vascular imaging techniques can spatially define mechanisms associated with tumor irradiation. Mol Cancer Res; 9(3); 259-70. (C) 2011 AACR.

    Original languageEnglish
    Pages (from-to)259-270
    Number of pages12
    JournalMolecular Cancer Research
    Issue number3
    Publication statusPublished - Mar 2011


    • Inducible factor 1
    • Contrast enhanced sonography
    • Magnetic resonance
    • Cancer therapy
    • Dilated cardiomyopathy
    • Inhibitor PX-478
    • Gene expression
    • Hypoxia
    • HIF-1
    • Angiogenesis


    Dive into the research topics of 'HIF-1-dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistance'. Together they form a unique fingerprint.

    Cite this